SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000929638-17-000875
Filing Date
2017-11-21
Accepted
2017-11-21 16:33:55
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G 86892
2 exhibit99-1.htm EX-99.1 6594
  Complete submission text file 0000929638-17-000875.txt   95146
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90187 | Film No.: 171217272
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LLC (Filed by) CIK: 0001583977 (see all company filings)

IRS No.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G